Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.
GHTC issued a statement at the 140th session of the World Health Organization (WHO) Executive Board supporting the assembly’s resolution on antimicrobial resistance (AMR), which incorporates R&D as a vital part of WHO’s strategy to combat AMR. The statement also calls for WHO to accelerate efforts to develop accountability frameworks to ensure AMR commitments are realized. The statement was issued in partnership with the Global Health Council and PATH.
GHTC issued a statement at the 140th session of the World Health Organization (WHO) Executive Board, welcoming efforts by WHO to advance frameworks to catalyze development of new technologies to combat potentially epidemic diseases and support regulatory models and procurement systems to accelerate the pace at which these tools reach patients. The statement was issued in partnership with the Global Health Council and PATH.
What global health advocates need to know about the President's "skinny" budget.